Tudor Investment Corporation »

Mineralys Therapeutics shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2025-12-31 $42M 1.2M 36.29

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
State Street SPDR S&P 500 ETF Trust - US ETP ETF Option Call Option (SPY)
Nvidia Corp - US Equity (NVDA)
Microsoft Corp - US Equity (MSFT)
Ishares Core S&P 500 Etf - US ETP ETF Option Call Option (IVV)
State Street Energy Select Sector SPDR ETF - US ET ETF Option Call Option (XLE)
Apple Inc - US Equity (AAPL)
Alphabet Equity (GOOGL)
Amazon.Com Inc - US Equity (AMZN)
Meta Platforms Inc - US Equity Option Call Option (META)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
State Street Financial Select Sector SPDR ETF - US ETF Option Call Option (XLF)
State Street Utilities Select Sector SPDR ETF - US ETF Option Call Option (XLU)
Spdr Gold Shares - US ETP ETF Option Call Option (GLD)

View all positions for Tudor Investment Corporation

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
Samsara BioCapital
Caligan Partners
FMR
BlackRock
Vanguard Group
State Street Corporation
Caption Management
Franklin Resources
Laurion Capital Management
Boothbay Fund Management
Holocene Advisors
Sr One Capital Management
Suvretta Capital Management

View all funds holding Mineralys Therapeutics